AOM Infusion ("AOM"), a leading specialty infusion pharmacy and provider, today announced it has joined Kedrion Biopharma’s limited distribution network for QIVIGY®, a new 10% immune globulin (Ig) ...
Today Kedrion Biopharma announced the nationwide commercial availability of QIVIGY, its FDA‑approved 10% Intravenous ...
6d
"I was fighting to survive": Patients still struggle with preauthorization despite promise of reform
Last summer, the Trump administration announced a voluntary pledge by health insurers to reform prior authorization, but patient advocates and medical providers remain skeptical.
KFF Health News on MSN
Families Scramble To Pay Five-Figure Bills as Clock Ticks on Promised Preauthorization Reforms
Last summer, the Trump administration announced a voluntary pledge by health insurers to reform prior authorization, which often requires patients or their doctors to seek preapproval from insurers ...
4d
A vitamin cocktail, straight to the vein. IV drip bars boom in Boston, but are they worth the hype?
Myers’ Cocktail: Perhaps the best-known IV blend, this mixture of vitamin C, B vitamins, magnesium, and calcium dates back to ...
Kelly for KFF Health News) March 14, 2026 - By Lauren Sausser - Sheldon Ekirch is used to being disappointed by her health insurance company. That’s why Ekirch, 31, of Henrico, Virginia, was stunned ...
The breakthrough treatment could lead to safer cancer therapies and may also help treat autoimmune diseases like lupus ...
This press release is intended for US audiences for transparency relative to global news for the Fabry community. This dosing regimen for ...
A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.
ADMA Biologics, Inc. (Nasdaq: ADMA) ("ADMA" or the "Company"), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results